Categories Analysis, Consumer

Despite slowdown, Procter & Gamble remains a good long-term investment

P&G ended fiscal 2022 on a mixed note, reporting fourth-quarter sales that topped expectations and weaker-than-expected core earnings

The consumer goods industry is one of the worst affected by the COVID-induced economic crisis and more recently the spiraling inflation. The Procter & Gamble Company (NYSE: PG), a leading consumer staples company that has been expanding market share constantly, is busy optimizing its global supply chain to ease the impact of challenges posed by the tough operating environment.

The market was not impressed by the company’s mixed fourth-quarter results that came last week — the stock experienced weakness in the following sessions. Short-term issues will continue to weigh on investor sentiment for some time, but P&G has what it takes to regain momentum and get back on track. While there are moderate risks that call for caution, the relatively low valuation can be seen as an entry point for long-term investors. It is widely expected that PG would bounce back and breach the $150-mark in the near future.

Sales Outlook

The Cincinnati-based company, which is specialized in personal care and hygiene products, sees a modest slowdown in sales due to the squeeze on consumers’ spending power. That would force the company and its retail customers to take a cautious pricing strategy. Elevated transportation costs and commodity prices would add to the pressure on profit margins. Still, P&G executives believe consumers would respond favorably to the price hikes being implemented.


Read management/analysts’ comments on P&G’s Q4 2022 results


The company that owns popular brands like Tide and Pampers sees risks to the business from macro headwinds like cost escalation and muted consumer sentiment. The management banks on the strategy of constructive disruption and agile organizational structure to beat the slump, which is expected to persist during the remainder of the year.

Procter & Gamble Q4 2022 Earnings Infographic

From P&G’s Q4 2022 earnings conference call:

“We’ve developed a productivity muscle that helps address some of the challenges we face. We remain fully committed to the cost and cash productivity in all facets of our business, up and down the income statement and across the balance sheet in each business and corporately. Productivity improvement is a necessity to drive balanced top and bottom-line growth and strong cash generation.”

Mixed Outcome

P&G ended fiscal 2022 on a mixed note, reporting fourth-quarter sales that topped expectations and weaker-than-expected core earnings, after beating bottom-line estimates regularly over the past several years. The top line rose a modest 3% to around $20 billion and net profit moved up 7% to $1.21 per share. Higher sales for the main operating segments more than offset weakness in the Beauty and Grooming divisions. A dip in sales volumes was compensated by higher prices in some product categories.

For fiscal 2023, the management issued sales guidance below the consensus forecast. Persistent uncertainties in key markets like China, where business is affected by COVID lockdown, and disruptions in Russia due to the Ukraine war would remain a drag on performance this year. The bottom line will be affected by higher costs and unfavorable foreign exchange rates, which has made the company forecast flat to low-single-digits earnings growth.


Kimberly-Clark Q1 profit drops but beats estimates; revenue up 7%


After entering 2022 on an upbeat note and peaking in the early weeks of the year, PG got caught up in the market selloff and maintained a downtrend since then. On Tuesday afternoon, the stock traded lower at around $142, which broadly matches its value 12 months ago.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results

Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to

Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?

The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment surrounding the company’s growth prospects. Pfizer has benefited

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top